Deficient Purposeful Use of Forepaws in Female Mice Modelling Rett Syndrome

Neural Plasticity

Volumn 2015, Issue , 2015, Pages

  De Filippis, Bianca ^a   Musto, Mattia ^a   Altabella, Luisa ^a   Romano, Emilia ^a   Canese, Rossella ^a   Laviola, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENERGY; BODY WEIGHT; BRAIN REGION; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; FOREFOOT; IN VIVO STUDY; MOTOR COORDINATION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RETT SYNDROME; SCORING SYSTEM; STRIATE CORTEX; TASK PERFORMANCE; ANIMAL; BRAIN CHEMISTRY; DISEASE MODEL; ENERGY METABOLISM; FORELIMB; GENETICS; GENOTYPE; METABOLISM; MOTIVATION; NEOSTRIATUM; NESTING; PHYSIOLOGY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE;

MECP2 PROTEIN, MOUSE; METHYL CPG BINDING PROTEIN 2;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FEMALE; FORELIMB; GENOTYPE; MAGNETIC RESONANCE SPECTROSCOPY; METHYL-CPG-BINDING PROTEIN 2; MICE; MOTIVATION; MOTOR SKILLS; NEOSTRIATUM; NESTING BEHAVIOR; PSYCHOMOTOR PERFORMANCE; RETT SYNDROME;

EID: 84936797698     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2015/326184     Document Type: Article

References (57)

1. R. E. Amir, I. B. vandenVeyver, M. Wan, C. Q. Tran, U. Francke, and H. Y. Zoghbi, "Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2, " Nature Genetics, vol. 23, no. 2, pp. 185-188, 1999.
2. J. Guy, H. Cheval, J. Selfridge, and A. Bird, "The role of MeCP2 in the brain, " Annual Review of Cell and Developmental Biology, vol. 27, pp. 631-652, 2011.
3. L. Ricceri, B. de Filippis, and G. Laviola, "Rett syndrome treatment in mouse models: searching for effective targets and strategies, " Neuropharmacology, vol. 68, pp. 106-115, 2013.
4. C. Einspieler, A. M. Kerr, and H. F. R. Prechtl, "Abnormal general movements in girls with Rett disorder: the first four months of life, " Brain and Development, vol. 27, no. 1, pp. S8-S13, 2005.
5. C. Einspieler, A. M. Kerr, and H. F. R. Prechtl, "Is the early development of girls with Rett disorder really normal?" Pediatric Research, vol. 57, no. 5, part 1, pp. 696-700, 2005.
6. B. Hagberg, "Clinical manifestations and stages of Rett syndrome, " Mental Retardation and Developmental Disabilities Research Reviews, vol. 8, no. 2, pp. 61-65, 2002.
7. D. M. Katz, J. E. Berger-Sweeney, J. H. Eubanks et al. , "Preclinical research in Rett syndrome: setting the foundation for translational success, "DMMDiseaseModels&Mechanisms, vol. 5, no. 6, pp. 733-745, 2012.
8. P. M. FitzGerald, J. Jankovic, and A. K. Percy, "Rett syndrome and associated movement disorders, " Movement Disorders, vol. 5, no. 3, pp. 195-202, 1990.
9. B. Hagberg, J. Aicardi, K. Dias, and O. Ramos, "A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome. Report of 35 cases, " Annals of Neurology, vol. 14, no. 4, pp. 471-479, 1983.
10. L. Ricceri, B. De Filippis, and G. Laviola, "Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches, " Behavioural Pharmacology, vol. 19, no. 5-6, pp. 501-517, 2008.
11. L. Robinson, A. Plano, S. Cobb, and G. Riedel, "Long-term home cage activity scans reveal lowered exploratory behaviour in symptomatic female Rett mice, " Behavioural Brain Research, vol. 250, pp. 148-156, 2013.
12. R. C. Samaco, C. M. Mcgraw, C. S. Ward, Y. Sun, J. L. Neul, and H. Y. Zoghbi, "FemaleMecp2+mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies, " HumanMolecular Genetics, vol. 22, no. 1, pp. 96-109, 2013.
13. L. R. Schaevitz, N. B. Gómez, D. P. Zhen, and J. E. Berger-Sweeney, "MeCP2 R168X male and female mutant mice exhibit Rett-like behavioral deficits, " Genes, Brain and Behavior, vol. 12, no. 7, pp. 732-740, 2013.
14. E. Wegener, C. Brendel, A. Fischer et al. , "Characterization of the MeCP2168 Knockin Mouse Model for Rett Syndrome, " PLoS ONE, vol. 9, no. 12, 2014.
15. K. K. Gadalla, P. D. Ross, J. S. Riddell, M. E. Bailey, S. R. Cobb, and N. Landsberger, "Gait analysis in aMecp2 knockoutmouse model of Rett syndrome reveals early-onset and progressive motor deficits, " PLoSONE, vol. 9, no. 11, Article IDe112889, 2014.
16. M. D. Shahbazian, J. I. Young, L. A. Yuva-Paylor et al. , "Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3, " Neuron, vol. 35, no. 2, pp. 243-254, 2002.
17. B. De Filippis, L. Ricceri, and G. Laviola, "Early postnatal behavioral changes in the Mecp2-308 truncation mouse model of Rett syndrome, " Genes, Brain and Behavior, vol. 9, no. 2, pp. 213-223, 2010.
18. A. Horská, L. Farage, G. Bibat et al. , "Brain metabolism in rett syndrome: age, clinical, and genotype correlations, " Annals of Neurology, vol. 65, no. 1, pp. 90-97, 2009.
19. S. Naidu, W. E. Kaufmann, M. T. Abrams et al. , "Neuroimaging studies in Rett syndrome, " Brain and Development, vol. 23, supplement 1, pp. S62-S71, 2001.
20. B. De Filippis, A. Fabbri, D. Simone et al. , "Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of rett syndrome, " Neuropsychopharmacology, vol. 37, no. 5, pp. 1152-1163, 2012.
21. K. A. Tennant, A. L. Asay, R. P. Allred, A. R. Ozburn, J. A. Kleim, and T. A. Jones, "The vermicelli and capellini handling tests: simple quantitative measures of dexterous forepaw function in rats and mice, " Journal of Visualized Experiments, no. 41, Article ID e2076, 2010.
22. V. Tucci, F. Achilli, G. Blanco et al. , "Reaching and grasping phenotypes in the mouse (Mus musculus): a characterization of inbred strains and mutant lines, " Neuroscience, vol. 147, no. 3, pp. 573-582, 2007.
23. P. Moretti, J. A. Bouwknecht, R. Teague, R. Paylor, and H. Y. Zoghbi, "Abnormalities of social interactions and homecage behavior in a mouse model of Rett syndrome, " Human Molecular Genetics, vol. 14, no. 2, pp. 205-220, 2005.
24. R. M. J. Deacon, "Assessing nest building in mice, " Nature Protocols, vol. 1, no. 3, pp. 1117-1119, 2006.
25. F. Zoratto, M. Fiore, S. F. Ali, G. Laviola, and S. Macr, "Neonatal tryptophan depletion and corticosterone supplementation modify emotional responses in adult male mice, " Psychoneuroendocrinology, vol. 38, no. 1, pp. 24-39, 2013.
26. R. Canese, E. M. Marco, F. de Pasquale, F. Podo, G. Laviola, andW. Adriani, "Differential response to specific 5-Ht(7) versus whole-serotonergic drugs in rat forebrains: a phMRI study, " NeuroImage, vol. 58, no. 3, pp. 885-894, 2011.
27. S. W. Provencher, "Estimation of metabolite concentrations from localized in vivo proton NMR spectra, " Magnetic Resonance in Medicine, vol. 30, no. 6, pp. 672-679, 1993.
28. W. Adriani, R. Canese, F. Podo, and G. Laviola, "1H MRSdetectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence, " Neurotoxicology and Teratology, vol. 29, no. 1, pp. 116-125, 2007.
29. R. Canese, M. E. Pisanu, D. Mezzanzanica et al. , "Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging, "NMR in Biomedicine, vol. 25, no. 4, pp. 632-642, 2012.
30. S. Macr, C. Ceci, R. Canese, andG. Laviola, "Prenatal stress and peripubertal stimulation of the endocannabinoid systemdifferentially regulate emotional responses and brain metabolism in mice, " PLoS ONE, vol. 7, no. 7, Article ID e41821, 2012.
31. A. Klein, L. -A. R. Sacrey, I. Q. Whishaw, and S. B. Dunnett, "The use of rodent skilled reaching as a translational model for investigating brain damage and disease, " Neuroscience and Biobehavioral Reviews, vol. 36, no. 3, pp. 1030-1042, 2012.
32. T. D. Farr and I. Q. Whishaw, "Quantitative and qualitative impairments in skilled reaching in the mouse (Mus musculus) after a focal motor cortex stroke, " Stroke, vol. 33, no. 7, pp. 1869-1875, 2002.
33. I. Q. Whishaw, B. L. K. Coles, S. M. Pellis, and E. I. Miklyaeva, "Impairments and compensation inmouth and limb use in free feeding after unilateral dopamine depletions in a rat analog of human Parkinson's disease, " Behavioural Brain Research, vol. 84, no. 1-2, pp. 167-177, 1997.
34. B. De Filippis, P. Nativio, A. Fabbri et al. , "Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for rett syndrome, " Neuropsychopharmacology, vol. 39, no. 11, pp. 2506-2518, 2014.
35. B. Kerr, M. Alvarez-saavedra, M. A. Sáez, A. Saona, and J. I. Young, "Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice, " Human Molecular Genetics, vol. 17, no. 12, pp. 1707-1717, 2008.
36. S. L. Fyffe, J. L. Neul, R. C. Samaco et al. , "Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress, " Neuron, vol. 59, no. 6, pp. 947-958, 2008.
37. R. H. Andres, A. D. Ducray, U. Schlattner, T. Wallimann, and H. R. Widmer, "Functions and effects of creatine in the central nervous system, " Brain Research Bulletin, vol. 76, no. 4, pp. 329-343, 2008.
38. R. A. Meyer, H. L. Sweeney, and M. J. Kushmerick, "A simple analysis of the 'phosphocreatine shuttle', " The American Journal of Physiology, vol. 246, no. 5, pp. C365-C377, 1984.
39. E. Trenkner, A. El Idrissi, and C. Harris, "Balanced interaction of growth factors and taurine regulate energy metabolism, neuronal survival, and function of cultured mouse cerebellar cells under depolarizing conditions, " Advances in Experimental Medicine and Biology, vol. 403, pp. 507-517, 1996.
40. S. W. Schaffer, J. Azuma, and M. Mozaffari, "Role of antioxidant activity of taurine in diabetes, " Canadian Journal of Physiology and Pharmacology, vol. 87, no. 2, pp. 91-99, 2009.
41. S. Parvez, H. Tabassum, B. D. Banerjee, and S. Raisuddin, "Taurine prevents tamoxifen-induced mitochondrial oxidative damage in mice, " Basic and Clinical Pharmacology and Toxicology, vol. 102, no. 4, pp. 382-387, 2008.
42. C. De Felice, F. Della Ragione, C. Signorini et al. , "Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome, " Neurobiology of Disease, vol. 68, pp. 66-77, 2014.
43. B. De Filippis, D. Valenti, V. Chiodi et al. , "Modulation of Rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome, " European Neuropsychopharmacology, vol. 25, no. 6, pp. 889-901, 2015.
44. B. De Filippis, D. Valenti, L. de Bari et al. , "Mitochondrial free radical overproduction due to respiratory chain impairment in the brain of a mouse model of Rett syndrome: protective effect of CNF1, " Free Radical Biology andMedicine, vol. 83, pp. 167-177, 2015.
45. R. M. Forbes-Lorman, J. R. Kurian, and A. P. Auger, "MeCP2 regulates GFAP expression within the developing brain, " Brain Research, vol. 1543, pp. 151-158, 2014.
46. D. M. Katz, J. E. Berger-Sweeney, J. H. Eubanks et al. , "Preclinical research in Rett syndrome: setting the foundation for translational success, " Disease Models and Mechanisms, vol. 5, no. 6, pp. 733-745, 2012.
47. Y. Asaka, D. G. M. Jugloff, L. Zhang, J. H. Eubanks, and R. M. Fitzsimonds, "Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome, " Neurobiology of Disease, vol. 21, no. 1, pp. 217-227, 2006.
48. C. A. Chapleau, G. D. Calfa, M. C. Lane et al. , "Dendritic spine pathologies in hippocampal pyramidal neurons fromRett syndrome brain and after expression of Rett-associatedMECP2 mutations, " Neurobiology of Disease, vol. 35, no. 2, pp. 219-233, 2009.
49. J. V. Deng, R. M. Rodriguiz, A. N. Hutchinson, I. H. Kim, W. C. Wetsel, and A. E. West, "MeCP2 in the nucleus accumbens contributes to neural and behavioral responses to psychostimulants, " Nature Neuroscience, vol. 13, no. 9, pp. 1128-1136, 2010.
50. P. Moretti, J. M. Levenson, F. Battaglia et al. , "Learning and memory and synaptic plasticity are impaired in a mouse model ofRett syndrome, " Journal ofNeuroscience, vol. 26, no. 1, pp. 319-327, 2006.
51. S. -M. Weng, F. McLeod, M. E. S. Bailey, and S. R. Cobb, "Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal, " Neuroscience, vol. 180, pp. 314-321, 2011.
52. M. E. Blue, S. Naidu, and M. V. Johnston, "Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome, " Experimental Neurology, vol. 156, no. 2, pp. 345-352, 1999.
53. H. G. Dunn, A. J. Stoessl, H. H. Ho et al. , "Rett Syndrome: investigation of nine patients, including PET scan, " Canadian Journal of Neurological Sciences, vol. 29, no. 4, pp. 345-357, 2002.
54. J. C. Harris, D. F. Wong, H. N. Wagner Jr. et al. , "Positron emission tomographic study of D2 dopamine receptor binding and CSF biogenic amine metabolites in Rett syndrome, " American Journal of Medical Genetics, vol. 24, no. 1, pp. 201-210, 1986.
55. F. -C. Kao, S. -H. Su, G. C. Carlson, and W. Liao, "MeCP2-mediated alterations of striatal features accompany psychomotor deficits in amouse model of Rett syndrome, " Brain Structure and Function, vol. 220, no. 1, pp. 419-434, 2015.
56. S. H. Su, F. C. Kao, Y. B. Huang, and W. Liao, "MeCP2 in the rostral striatum maintains local dopamine content critical for psychomotor control, " Journal of Neuroscience, vol. 35, no. 15, pp. 6209-6220, 2015.
57. K. Szczesna, O. de la Caridad, P. Petazzi et al. , "Improvement of the rett syndrome phenotype in a mecp2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor, " Neuropsychopharmacology, vol. 39, no. 12, pp. 2846-2856, 2014.